Back to Journals » Journal of Hepatocellular Carcinoma

Impact Factor

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969

Journal Articles:

- 581 records -

Original Research

Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study

Hu Z, Zhou H

Journal of Hepatocellular Carcinoma 2024, 11:767-774

Published Date: 24 April 2024

Original Research

A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation

Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2024, 11:747-766

Published Date: 23 April 2024

Original Research

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis

Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y

Journal of Hepatocellular Carcinoma 2024, 11:737-746

Published Date: 18 April 2024

Original Research

Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study

Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B

Journal of Hepatocellular Carcinoma 2024, 11:721-735

Published Date: 8 April 2024

Review

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I

Journal of Hepatocellular Carcinoma 2024, 11:707-719

Published Date: 6 April 2024

Original Research

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy

Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z

Journal of Hepatocellular Carcinoma 2024, 11:693-705

Published Date: 4 April 2024

Original Research

Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery

Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J

Journal of Hepatocellular Carcinoma 2024, 11:679-691

Published Date: 3 April 2024

Original Research

Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis

Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R

Journal of Hepatocellular Carcinoma 2024, 11:665-678

Published Date: 4 April 2024

Original Research

High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization

Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D

Journal of Hepatocellular Carcinoma 2024, 11:651-663

Published Date: 27 March 2024

Review

The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

Chen W, Hu Z, Li G, Zhang L, Li T

Journal of Hepatocellular Carcinoma 2024, 11:629-649

Published Date: 27 March 2024

Original Research

The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients

Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K

Journal of Hepatocellular Carcinoma 2024, 11:619-628

Published Date: 25 March 2024

Original Research

Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions

Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H

Journal of Hepatocellular Carcinoma 2024, 11:607-618

Published Date: 23 March 2024

Original Research

Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK

Journal of Hepatocellular Carcinoma 2024, 11:595-606

Published Date: 20 March 2024

Review

Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma

Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G

Journal of Hepatocellular Carcinoma 2024, 11:581-594

Published Date: 19 March 2024

Original Research

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro

Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF

Journal of Hepatocellular Carcinoma 2024, 11:565-580

Published Date: 19 March 2024

Corrigendum

Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X

Journal of Hepatocellular Carcinoma 2024, 11:563-564

Published Date: 14 March 2024

Original Research

LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J

Journal of Hepatocellular Carcinoma 2024, 11:543-562

Published Date: 11 March 2024

Original Research

A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma

Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B

Journal of Hepatocellular Carcinoma 2024, 11:525-542

Published Date: 12 March 2024

Original Research

Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy

Qiao W, Sheng S, Li J, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:509-523

Published Date: 7 March 2024

Original Research

Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation

Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J

Journal of Hepatocellular Carcinoma 2024, 11:489-508

Published Date: 6 March 2024

Original Research

Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma

Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:477-488

Published Date: 4 March 2024

Original Research

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy

Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2024, 11:463-475

Published Date: 4 March 2024

Original Research

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Chamseddine S, LaPelusa M, Xiao L, Mohamed YI, Lee SS, Hu ZI, Hatia RI, Hassan M, Yao JC, Duda DG, Datar S, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2024, 11:455-461

Published Date: 4 March 2024

Original Research

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma

Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK

Journal of Hepatocellular Carcinoma 2024, 11:443-454

Published Date: 5 March 2024

Original Research

Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter Study

Wang F, Yan CY, Qin Y, Wang ZM, Liu D, He Y, Yang M, Wen L, Zhang D

Journal of Hepatocellular Carcinoma 2024, 11:427-442

Published Date: 29 February 2024

Original Research

Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers

Huang C, Xiao X, Tong L, Gao Z, Ji J, Zhou L, Li Y, Liu L, Feng H, Fang M, Gao C

Journal of Hepatocellular Carcinoma 2024, 11:411-425

Published Date: 27 February 2024

Original Research

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study

Cai H, Chen S, Wu Z, Wang F, Tang S, Chen L, Guo W

Journal of Hepatocellular Carcinoma 2024, 11:399-409

Published Date: 26 February 2024

Original Research

A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization

Sun Z, Li X, Liang H, Shi Z, Ren H

Journal of Hepatocellular Carcinoma 2024, 11:385-397

Published Date: 26 February 2024

Original Research

Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment

Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J

Journal of Hepatocellular Carcinoma 2024, 11:373-383

Published Date: 22 February 2024

Review

Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?

Himmelsbach V, Koch C, Trojan J, Finkelmeier F

Journal of Hepatocellular Carcinoma 2024, 11:363-372

Published Date: 19 February 2024

Expert Opinion

Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia

Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S

Journal of Hepatocellular Carcinoma 2024, 11:349-362

Published Date: 16 February 2024

Response to Letter

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]

Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y

Journal of Hepatocellular Carcinoma 2024, 11:347-348

Published Date: 14 February 2024

Review

Lipid Metabolism as a Potential Target of Liver Cancer

Wu K, Lin F

Journal of Hepatocellular Carcinoma 2024, 11:327-346

Published Date: 14 February 2024

Original Research

The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions

Luo QQ, Li QN, Cai D, Jiang S, Liu SS, Liu MS, Lv C, Wang JK, Zhang KH, Wang T

Journal of Hepatocellular Carcinoma 2024, 11:317-325

Published Date: 8 February 2024

Original Research

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy

Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J

Journal of Hepatocellular Carcinoma 2024, 11:305-316

Published Date: 8 February 2024

Original Research

RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer

Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, Yin HH, Lu CM, Wen DY, He Y, Yang H

Journal of Hepatocellular Carcinoma 2024, 11:285-304

Published Date: 5 February 2024

Original Research

Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation

Qiao W, Li J, Wang Q, Jin R, Zhang H

Journal of Hepatocellular Carcinoma 2024, 11:271-284

Published Date: 3 February 2024

Original Research

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y

Journal of Hepatocellular Carcinoma 2024, 11:257-269

Published Date: 3 February 2024

Original Research